Matinas BioPharma Holdings, Inc.

Industry

  • Pharmaceuticals
    • Drug Delivery
    • Specialty Pharmaceuticals
  • Biotechnology
    • Drug Discovery Technologies
      • Molecular Diversity
        • Natural Products

Other Names/Subsidiaries

  • Aquarius Biotechnologies
See more in Biomedtracker

Latest on Matinas BioPharma Holdings, Inc.

Scrip

BioNTech Bolsters Cancer Immunotherapy Ambitions In Pact With Cash-Poor Ryvu

 
• By Joseph Haas

Who: BioNTech SE/Ryvu Therapeutics What: Ryvu licenses its STING agonist portfolio to BioNTech and also inks a multi-target research collaboration to advance small molecule immune modulators for ca

Scrip

Deal Watch: Dragonfly Adds Gilead To Its List Of Big-Name Partners

 
• By Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Gilead Gets 5T4-Targeted NK Cell Therap

Scrip

AZ Halts Epanova Study As High Placebo Effect Kills Acasti’s Omega-3 TRILOGY-1 Trial

 
• By Sten Stovall

AstraZeneca PLC ’s hopes of emulating Amarin Corp. PLC ’s Vascepa with its omega-3 product Epanova have been hit just as commercial prospects were put on hold for Acasti Pharma Inc. 's similar produ

Scrip

Deal Watch: Parvus Signs Second Big Pharma Alliance, With Genentech

 
• By Joseph Haas, Ian Haydock, and Anju Ghangurde

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Parvus, Genentech Collaborat